Claims
- 1. A compound of formula:
- R.sup.1 --Z--CHR.sup.2 --A (I)
- wherein:
- A is -BY.sup.1 Y.sup.2 ;
- Y.sup.1 and Y.sup.2 are independently
- a) --OH,
- b) --F
- c) --NR.sup.3 R.sup.4, or
- d) C.sub.1 -C.sub.8 alkoxy;
- Y.sup.1 and y.sup.2 are taken together to form:
- e) a cyclic boron ester where said chain or ring contains from 2 to 20 carbon atoms and, from 0-3 heteroatoms which are N, S, or O,
- f) a cyclic boron amide where said chain or ring contains from 2 to 20 carbon atoms and, from 0-3 heteroatoms which are N, S, or O,
- g) a cyclic boron amide-ester where said chain or ring contains from 2 to 20 carbon atoms and from 0-3 heteroatoms which are N, S, or O;
- Z is
- a) --(CH.sub.2).sub.m CONR.sup.8 --,
- b) --(CH.sub.2).sub.m CSNR.sup.8 --,
- c) --(CH.sub.2).sub.m SO.sub.2 NR.sup.8 --,
- d) --(CH.sub.2).sub.m CO.sub.2 --,
- e) --(CH.sub.2).sub.m C(S)O--, or
- f) --(CH.sub.2).sub.m SO.sub.2 O--;
- R.sup.1 is --(CH.sub.2).sub.p -aryl, wherein aryl is phenyl, naphthyl or biphenyl substituted with one, two or three substituents selected from the group consisting of:
- halo, methylenedioxy, -R.sup.8, --NR.sup.8 COR.sup.9, C.sub.2 -C.sub.6 -alkenyl, C.sub.2 -C.sub.6 -alkynyl, --(CH.sub.2).sub.w --OR.sup.8, -(C.sub.1 -C.sub.6)-perfluoroalkyl, --(CH.sub.2).sub.w CN, --(CH.sub.2).sub.w NC, --(CH.sub.2).sub.w NO.sub.2, --(CH.sub.2).sub.w CF.sub.3, --(CH.sub.2).sub.w S(O).sub.r R.sup.7, --(CH.sub.2).sub.w NR.sup.8 R.sup.9, --(CH.sub.2).sub.w COR.sup.8, --(CH.sub.2).sub.w CHO; --(CH.sub.2).sub.w CO.sub.2 R.sup.8, --(CH.sub.2).sub.w CONR.sup.8 R.sup.9, --(CH.sub.2).sub.w SO.sub.2 NH--(C.sub.1 -C.sub.5)-alkyl, --(CH.sub.2).sub.w SO.sub.2 NH.sub.2, --(CH.sub.2).sub.w SO.sub.2 NH--CO--(C.sub.1 -C.sub.6)-alkyl, --(CH.sub.2).sub.w SO.sub.2 NH--CO.sub.2 --(C.sub.1 -C.sub.6)-alkyl, --(CH.sub.2).sub.w NHSO.sub.2 --(C.sub.1 -C.sub.6)-alkyl, --(CH.sub.2).sub.w NHSO.sub.2 --(C.sub.1 -C.sub.6)-perfluoroalkyl, --(CH.sub.2).sub.w NHSO.sub.2 -phenyl, --(CH.sub.2).sub.w NHSO.sub.2 -perfluorophenyl, --(CH.sub.2).sub.w CN.sub.4 H, --O(CH.sub.2).sub.w CN, --NH(CH.sub.2).sub.w CN, --S(CH.sub.2).sub.w CN, --(CH.sub.2).sub.w NH--CO--(C.sub.1 -C.sub.6 -alkyl), --(CH.sub.2).sub.w NH--CO--(C.sub.1 -C.sub.6 -perfluoroalkyl), --(CH.sub.2).sub.w NH--CO--(phenyl), --(CH.sub.2).sub.w NH--CO.sub.2 --(C.sub.1 -C.sub.6 -alkyl), --(CH.sub.2).sub.w NH--CO.sub.2 --(C.sub.1 -C.sub.6 -perfluoroalkyl), --(CH.sub.2).sub.w NH--CO.sub.2 --(phenyl), --O(C.dbd.O)--(C.sub.1 -C.sub.5 -alkyl), ##STR157## R.sup.2 is a) -(C.sub.1 -C.sub.12 alkyl)-X,
- b) -(C.sub.2 -C.sub.12 alkenyl)-X, or ##STR158## X is a) halogen,
- b) --CN,
- c) --NO.sub.2,
- d) --CF.sub.3,
- e) --S(O).sub.r R14,
- f) --NHR.sup.14
- g) --NHS(O).sub.r R.sup.14,
- h) --NHC(NH)H,
- i) --NHC(NH)NHOH,
- j) --NHC(NH)NHCN,
- k) --NHC(NH)NHR.sup.14,
- l) --NHC(NH)NHCOR.sup.14,
- m) --C(NH)NHR.sup.14,
- n) --C(NH)NHCOR.sup.14,
- o) --C(O)NHR.sup.14,
- p) --C(O)NHC(O)R.sup.14,
- q) --C(O)OR.sup.14,
- r) --OR.sup.14,
- s) --OC(O)R.sup.14,
- t) --OC(O)OR.sup.14,
- u) --OC(O)NHR.sup.14,
- v) --OC(O)NHC(O)R.sup.14,
- w) --SC(.dbd.NH).sup.NHR.sup.14, or
- x) --SC(.dbd.NH)NHC(.dbd.O)R.sup.14 ;
- R.sup.3 is
- a) hydrogen,
- b) C.sub.1 -C.sub.8 alkyl,
- c) -(C.sub.1 -C.sub.4 alkyl)-aryl,
- d) C.sub.5 -C.sub.7 cycloalkyl, or
- e) phenyl;
- R.sup.4 is
- a) hydrogen,
- b) C.sub.1 -C.sub.8 alkyl,
- c) --(C.sub.1 -C.sub.4 alkyl)-aryl,
- d) C.sub.5 -C.sub.7 cycloalkyl,
- e) phenyl, or
- f) phenylsulfonyl;
- R.sup.7 is
- a) phenyl,
- b) C.sub.1 -C.sub.8 -alkyl,
- c) C.sub.1 -C.sub.4 -alkoxy,
- d) --CF.sub.3, or
- e) benzyl;
- R.sup.8 and R.sup.9 are independently
- a) H, ##STR159## c) C.sub.3 -C.sub.7 cycloalkyl, d) C.sub.1 -C.sub.8 -alkyl, or
- R.sup.11 is
- a) halo,
- b) --CN,
- c) C.sub.1 -C.sub.10 -alkyl,
- d) C.sub.3 -C.sub.8 -cycloalkyl,
- e) C.sub.2 -C.sub.10 -alkenyl,
- f) C.sub.2 -C.sub.10 -alkynyl,
- g) --OR.sup.8,
- h) --NO.sub.2,
- i) --CF.sub.3,
- j) --S(O).sub.r R.sup.7,
- k) --NR.sup.8 R.sup.9,
- m) --CO.sub.2 R.sup.8,
- l) --COR.sup.9,
- n) --CONR.sup.8 R.sup.9, or
- o) H
- R.sup.12 is H, C.sub.1 -C.sub.4 alkyl, phenyl, benzyl, --COR.sup.7, or --S(O).sub.r R.sup.7 ;
- R14 is
- a) --H,
- b) --CF.sub.3
- c) --C.sub.1 -C.sub.4 alkyl,
- d) --(CH.sub.2).sub.q -aryl, wherein aryl is phenyl, biphenyl, naphthyl, or fluorenyl unsubstituted or substituted with one to three substituents selected from the group consisting of:
- halogen,
- --CF.sub.3,
- -(C.sub.1 -C.sub.4 alkyl),
- --(CH.sub.2).sub.x R.sup.15,
- --(CH.sub.2).sub.x CO(CH.sub.2).sub.y R.sup.15,
- --(CH.sub.2).sub.x C(O)O(CH.sub.2).sub.y R.sup.15,
- --(CH.sub.2).sub.x C(O)N�(CH.sub.2).sub.y R.sup.15 !�(CH.sub.2).sub.y R.sup.16 !,
- -methylenedioxy,
- -(C.sub.1 -C.sub.4 alkoxy),
- --(CH.sub.2).sub.x O(CH.sub.2).sub.y R.sup.15,
- --(CH.sub.2).sub.x OCO(CH.sub.2).sub.y R.sup.15,
- --(CH.sub.2).sub.x OC(O)O(CH.sub.2).sub.y R.sup.15,
- --(CH.sub.2).sub.x OC(O)N�(CH.sub.2).sub.y R.sup.15 !�(CH.sub.2).sub.y R.sup.16 !,
- --(CH.sub.2).sub.x OC(O)N�(CH.sub.2).sub.y R.sup.15 !�CO(CH.sub.2).sub.y R.sup.16 !,
- --(CH.sub.2).sub.x S(O).sub.r (CH.sub.2).sub.y R.sup.15,
- --(CH.sub.2).sub.x S(O).sub.r (CH.sub.2).sub.y COR.sup.15,
- --(CH.sub.2).sub.x S(O).sub.r (CH.sub.2).sub.y C(O)OR.sup.15,
- --(CH.sub.2).sub.x S(O).sub.r N�(CH.sub.2).sub.y R.sup.15 !�(CH.sub.2).sub.y R.sup.16 !
- --(CH.sub.2).sub.x N�(CH.sub.2).sub.y R.sup.15 !�(CH.sub.2).sub.y R.sup.16 !,
- --(CH.sub.2).sub.x N�(CH.sub.2).sub.y R.sup.15 !�CO(CH.sub.2).sub.y R.sup.16 !,
- --(CH.sub.2).sub.x N�(CH.sub.2).sub.y R.sup.15 !�C(O)O(CH.sub.2).sub.y R.sup.16 !,
- --(CH.sub.2).sub.x N�(CH.sub.2).sub.y R.sup.15 !CON�(CH.sub.2).sub.y R.sup.15 !�(CH.sub.2).sub.y R.sup.16 !,
- --(CH.sub.2).sub.x N�(CH.sub.2).sub.y R.sup.15 !CON�(CH.sub.2).sub.y R.sup.15 !--�CO(CH.sub.2).sub.y R.sup.16 !,
- --(CH.sub.2).sub.x N�(CH.sub.2).sub.y R.sup.15 !�S(O).sub.r (CH.sub.2).sub.y R.sup.16 !;
- R.sup.15 and R.sup.16 are independently
- a) hydrogen,
- b) C.sub.1 -C.sub.8 alkyl,
- c) -(C.sub.1 -C.sub.4 alkyl)-aryl, where aryl is defined above,
- d) C.sub.5 -C.sub.7 cycloalkyl,
- e) phenyl, substituted by 0-3 R.sup.18,
- f) benzyl, substituted by 0-3 R.sup.18, or
- g) --(C.sub.1 -C.sub.4 alkoxy);
- R.sup.15 and R.sup.16 are taken together to form a ring: ##STR160## m is 0 to 6; n is 1 to 2;
- p is 0 to 2;
- q is 0 to 4.
- r is 0 to 2;
- s is 0 to 3;
- t is 1 to 5;
- u is 0 to 5;
- w is 0 to 5;
- x is 0 to 6;
- y is 0 to 6;
- W is
- a) --O--,
- b) --S(O).sub.r,
- c) --NR.sup.4 --,
- d) --NC(.dbd.O)R.sup.3 --,
- e) a bond, or
- f) --(CH.sub.2).sub.n --;
- or pharmaceutically acceptable salts thereof.
- 2. A compound of claim 1 wherein:
- Z is
- a) --(CH.sub.2).sub.m CONR.sup.8 --,
- b) --(CH.sub.2).sub.m CSNR.sup.8 --,
- c) --(CH.sub.2).sub.m SO.sub.2 NR.sup.8 --,
- R.sup.1 is --(CH.sub.2).sub.p -aryl, wherein aryl is phenyl, naphthyl or biphenyl substituted with one, two or three substituents selected from the group consisting of:
- halo, methylenedioxy, -R.sup.8, --NR.sup.8 COR.sup.9, C.sub.2 -C.sub.6 -alkenyl, C.sub.2 -C.sub.6 -alkynyl, --(CH.sub.2).sub.w --OR.sup.8, --(C.sub.1 -C.sub.6)-perfluoroalkyl, --(CH.sub.2).sub.w CN, --(CH.sub.2).sub.w NC, --(CH.sub.2).sub.w NO.sub.2, --(CH.sub.2).sub.w CF.sub.3, --(CH.sub.2).sub.w S(O).sub.r R.sup.7, --(CH.sub.2).sub.w NR.sup.8 R.sup.9, --(CH.sub.2).sub.w COR.sup.8, --(CH.sub.2).sub.w CO.sub.2 R.sup.8, --(CH.sub.2).sub.w CONR.sup.8 R.sup.9. --(CH.sub.2).sub.w SO.sub.2 NH--(C.sub.1 -C.sub.6)-alkyl, --(CH.sub.2).sub.w SO.sub.2 NH.sub.2, --(CH.sub.2).sub.w SO.sub.2 NH--CO--(C.sub.1 -C.sub.6)--alkyl, --(CH.sub.2).sub.w SO.sub.2 NH--CO.sub.2 --(C.sub.1 -C.sub.6)-alkyl, --(CH.sub.2).sub.w NHSO.sub.2 --(C.sub.1 -C.sub.6)-alkyl, --(CH.sub.2).sub.w NHSO.sub.2 --(C.sub.1 -C.sub.6)-perfluoroalkyl, --(CH.sub.2).sub.w NHSO.sub.2 -phenyl, --(CH.sub.2).sub.w NHSO.sub.2 -perfluorophenyl, --(CH.sub.2).sub.w CN.sub.4 H, --O(CH.sub.2).sub.w CN, --NH(CH.sub.2).sub.w CN, --S(CH.sub.2).sub.w CN, --(CH.sub.2).sub.w NH--CO--(C.sub.1 -C.sub.6 -alkyl), --(CH.sub.2).sub.w NH--CO--(C.sub.1 -C.sub.6 -perfluoroalkyl), --(CH.sub.2).sub.w NH--CO--(phenyl), --(CH.sub.2).sub.w NH--CO.sub.2 --(C.sub.1 -C.sub.6 -alkyl), --(CH.sub.2).sub.w NH--CO.sub.2 --(C.sub.1 -C.sub.6 -perfluoroalkyl), or --(CH.sub.2).sub.w NH--CO.sub.2 --(phenyl), --O(C.dbd.O--(C.sub.1 -C.sub.5 alkyl);
- R.sup.14 is:
- a) --H,
- b) --CF.sub.3
- c) -C.sub.1 -C.sub.4 alkyl,
- d) --(CH.sub.2).sub.q -aryl, wherein aryl is phenyl, biphenyl, naphthyl, or fluorenyl unsubstituted or substituted with one to three substituents selected from the group consisting of:
- halogen
- --CF.sub.3,
- -(C.sub.1 -C.sub.4 alkyl),
- -methylenedioxy,
- -(C.sub.1 -C.sub.4 alkoxy),
- --(CH.sub.2).sub.x N�(CH.sub.2).sub.y R.sup.15 !�(CH.sub.2).sub.y R.sup.16 !; and all other required substituents of formula (I) are as defined in claim 1.
- 3. A compound of claim 2 wherein
- A is -BY.sup.1 Y.sup.2 ;
- Y.sup.1 and Y.sup.2 are independently
- a) --OH, or
- b) C.sub.1 -C.sub.8 alkoxy;
- Y.sup.1 and Y.sup.2 are taken together to form
- a cyclic boron ester where said chain or ring contains from 2 to 20 carbon atoms and from 0-3 heteroatoms which are N, S, or O,
- X is
- a) halogen
- b) --CN,
- c) --NO.sub.2,
- d) --CF.sub.3,
- e) --NHR.sup.14
- f) --NHS(O).sub.r R.sup.14,
- g) --NHC(NH)H,
- h) --NHC(NH)NHOH,
- i) --NHC(NH)NHCN,
- j) --NHC(NH)NHR.sup.14,
- k) --NHC(NH)NHCOR.sup.14,
- l) --C(NH)NHR.sup.14,
- m) --C(NH)NHCOR.sup.14,
- n) --C(O)NHR.sup.14,
- o) --C(O)NHC(O) R.sup.14,
- p) --C(O)OR.sup.14,
- q) --OR.sup.14,
- r) --OC(O)R.sup.14,
- s) --OC(O)OR.sup.14,
- t) --OC(O)NHR.sup.14,
- u) --OC(O)NHC(O) R.sup.14,
- v) --SC(.dbd.NH)NHR.sup.14, or
- w) --SC(.dbd.NH)NHC(.dbd.O) R.sup.14 ;
- W is
- a) --O--,
- b) --NR.sup.4 --,
- c) a bond, or
- d) --(CH.sub.2).sub.n --;
- and all other required substituents of formula (I) are as in claim 2.
- 4. A compound of claim 3 wherein:
- Z is --(CH.sub.2).sub.m CONR.sup.8 --;
- R.sup.2 is
- a) -(C1-C12 alkyl)-X, or ##STR161## X is a) halogen (F, Cl, Br, I),
- b) --CN,
- c) --NHR.sup.14
- d) --NHC(NH) H,
- e) --NHC(NH) NHR.sup.14,
- f) --C(NH)NHR.sup.14,
- g) --OR.sup.14, or
- h) --SC(.dbd.NH) NHR.sup.14 ;
- R.sup.14 is --H;
- and all other required substituents of formula (I) are defined as in claim 3.
- 5. A compound of claim 4 selected from the group consisting of:
- N.sup.1 -(4-phenylbenzoyl)-(R)-boroarginine, hydrochloride
- N.sup.1 -(3-phenoxybenzoyl)-(R)-boroarginine, hydrochloride
- N.sup.1 -(1-fluorenonyl)-(R)-boroarginine, hydrochloride
- N.sup.1 -(4-�1-butyl!benzoyl)-(R)-boroarginine, hydrochloride
- N.sup.1 -(2-benzoylbenzoyl)-(R)-boroarginine, hydrochloride
- N.sup.1 -(3-�N-benzyloxycarbonyl-N-methylamino!-4-�1-butyl!-benzoyl)-(R)-boroarginine, hydrochloride
- N.sup.1 -(4-cyclohexylbenzoyl)-(R)-boroarginine, hydrochloride
- N.sup.1 -(2-methyl-4-phenylbenzoyl)-(R)-boroarginine, hydrochloride
- N.sup.1 -�4-phenyl-2-nitrobenzoyl!boroArg, (+)-pinanediol ester
- N.sup.1 -�4-phenyl-2-fluorobenzoyl!boroArg, (+)-pinanediol ester
- N.sup.1 -�4-phenyl-2-aminobenzoyl!boroArg, (+)-pinanediol ester
- N.sup.1 -�4-phenyl-2-(methylsulfonamido)benzoyl!boroArg, (+)-pinanediol ester
- N.sup.1 -�4-phenyl-2-(cyanomethylamino)benzoyl!boroArg, (+)-pinanediol ester
- N.sup.1 -�4-phenyl-2-(cyanomethyl)benzoyl!boroArg, (+)-pinanediol ester
- N.sup.1 -�4-phenyl-2-(diethylamino)benzoyl!boroArg, (+)-pinanediol ester
- N.sup.1 -�4-�2-(t-butylaminosulfonyl)phenyl!-2-methyl-benzoyl!boroArg, (+)pinanediol ester
- N.sup.1 -�4-�2-(aminosulfonyl)phenyl!-2-methyl-benzoyl!boroArg, (+)pinanediol ester
- N.sup.1 -�4-�2-(methoxycarbonylaminosulfonyl)phenyl!-2-methyl-benzoyl!boroArg, (+)-pinanediol ester
- N.sup.1 -�4-�2-(t-butylaminosulfonyl)phenyl!benzoyl!boroArg, (+)-pinanediol ester
- N.sup.1 -�4-�2-(t-butylaminosulfonyl)phenyl!benzoyl!boroArg--OH
- N.sup.1 -�4-�2-(n-butoxycarbonylaminosulfonyl)phenyl!-2-methyl-benzoyl!boroArg, (+)-pinanediol ester
- N.sup.1 -�4-�2-(diethylaminosulfonyl)phenyl!-2-methyl-benzoyl!boroArg, (+)pinanediol ester
- N.sup.1 -�4-�2-(t-butylaminosulfonyl)phenyl!-2-fluoro-benzoyl!boroArg, (+)pinanediol ester
- N.sup.1 -�4-�2-(aminosulfonyl)phenyl!-2-fluoro-benzoyl!boroArg, (+)pinanediol ester
- N.sup.1 -�4-�2-(methoxycarbonylaminosulfonyl)phenyl!-2-fluoro-benzoyl!boroArg, (+)-pinanediol ester
- N.sup.1 -�4-�2-(t-butylaminosulfonyl)phenyl!-2-nitro-benzoyl!boroArg, (+)pinanediol ester
- N.sup.1 -�4-�2-(aminosulfonyl)phenyl!-2-nitro-benzoyl!boroArg, (+)pinanediol ester
- N.sup.1 -�4-�2-(methoxycarbonylaminosulfonyl)phenyl!-2-nitro-benzoyl!boroArg, (+)-pinanediol ester
- N.sup.1 -(3-phenylbenzoyl)boroarg, (+)-pinanediol
- N.sup.1 -�4-(3-BOCNHphenyl).sub.2 -methylbenzoyl!boroarg, (+)-pinanediol
- N.sup.1 -�4-(3-nitrophenyl)benzoyl!boroarg, (+)-pinanediol
- N.sup.1 -�4-(3-aminophenyl)benzoyl!boroarg, (+)-pinanediol
- N.sup.1 -(3-phenylbenzoyl)borolys, (+)-pinanediol and
- N.sup.1 -(3-phenylbenzoyl)boroIrg, (+)-pinanediol.
- 6. A pharmaceutical composition comprising a pharmaceutically acceptable carrier and a therapeutically effective amount of a compound of any one of claims 1 through 5.
- 7. A method of treating a physiological disorder in a warm blooded animal catalyzed by trypsin-like enzymes comprising administering to an animal in need of such treatment an effective amount of a compound of any one of claims 1 through 5.
Parent Case Info
This is a division of application Ser. No. 08/364,338, filed Dec. 27, 1994, now U.S. Pat. No. 5,563,127 which is a continuation-in-part of U.S. patent application Ser. No. 8/348/029, filed Dec. 1, 1994, now abandoned, which is a continuation-in-part of U.S. patent application Ser. No. 08/318/029, filed Oct. 4, 1994, now abandoned, which is a continuation-in-part of U.S. patent application Ser. No. 08/036/377, filed Mar. 24, 1993, now abandoned.
US Referenced Citations (1)
Number |
Name |
Date |
Kind |
4963655 |
Kinder et al. |
Oct 1990 |
|
Non-Patent Literature Citations (4)
Entry |
CA87:163396u Amino methaneboronic acids. Synthesis . . . substrates. Lindquist et al., p. 195, 1977. |
CA101:225600z Benzamidomethane boronic acid: . . . chymotrypsin. Amiri et al., p. 341, 1984. |
CA108:218119r .beta.-lactamase . . . boronic acids. Crompton et al., p. 243, 1988. |
CA 121:136648s Liquid . . . enzyme stability.Labeque et al., p. 140, 1994. |
Divisions (1)
|
Number |
Date |
Country |
Parent |
364338 |
Dec 1994 |
|
Continuation in Parts (3)
|
Number |
Date |
Country |
Parent |
348029 |
Dec 1994 |
|
Parent |
318029 |
Oct 1994 |
|
Parent |
36377 |
Mar 1993 |
|